Red Light Holland Initiates Psilocybin Extraction Phase With PharmAla Following Successful Testing and Preparation by CCrest Labs

With the successful testing and preparation of our psilocybin truffles at CCrest Labs, we are now moving into an exciting phase of extraction with PharmAla.

newsfileApr 23 20:11

Press Release: PharmAla Closes Private Placement and Concurrent Debt Settlement

PharmAla Closes Private Placement and Concurrent Debt Settlement VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDM

Dow JonesApr 19 20:35

Press Release: PharmAla Biotech Signs Sale Agreement With Numinus

PharmAla Biotech Signs Sale Agreement with Numinus LaNeo Product Data submitted for a Clinical Trial in Canada TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla"

Dow JonesMar 26 20:55

PharmAla Says Patent Allowance Granted for P-1 Molecule by USPTO

PharmAla Biotech Holdings Inc. (MDMA.CN) focused on the research, development, and manufacturing of LaNeo MDMA and novel derivatives of MDMA (MDXX class molecules), announces that allowance has been g

MT NewswiresMar 20 23:36

Red Light Holland Commences Experimental Research on Psilocybin Truffles to Develop Process for Commercial Manufacturing of Natural-Source Active Pharmaceutical Ingredient

Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth a

newsfileMar 8 21:05

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

PharmAla Biotech Holdings Inc. (MDMA.CSE), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo MDMA and novel MDXX compounds, and Filament Health Corp.,

MT NewswiresNov 16, 2023 01:28